Rewiring Biological Time and Aging with Epigenome Editing
Charles A. Gersbach, PhD
The bright, new future of therapeutic epigenome editing is already on our doorstep
CRISPR
New CRISPR Toolkit to Allow Remote-Controlled Genome Editing
University of Southern California
USC Viterbi biomedical engineers harness focused ultrasound to revolutionize CRISPR’s capabilities to treat countless diseases
Enhancing the Precision of CRISPR-Based Gene Editing
Today's Clinical Lab
A new interdisciplinary project at Lehigh University aims to leverage AI and advanced modeling to refine CRISPR gene editing, enhancing safety and expanding its medical applications
New Gene Editing Tool Rapidly Screens Cancer Mutations
Massachusetts Institute of Technology
With the new technique, researchers hope to identify mutations that could be targeted with new cancer therapies
New Screening Tool Unveils Impact of Disease-Causing Mutations
Wellcome Trust Sanger Institute
Integrated single-cell approach to cellular genetic screening uncovers mechanisms driving cancer and autoimmunity
FDA Approves First Gene Therapies for Sickle Cell Disease
U.S. Food and Drug Administration
The FDA granted the approval of Casgevy to Vertex Pharmaceuticals Inc., and Lyfgenia to Bluebird Bio Inc.
Latest Study Dives Deeper into T-Cell Activation and Response
La Jolla Institute for Immunology
How do T-cell receptors on the cell surface alert the nucleus far inside the cell of trouble?
Genomic Medicine Milestones: The Resurgence of CRISPR Gene Editing
Rachel Diamant, MSc
The future of genomic medicine relies on technical considerations and ongoing industry collaboration
CRISPR-Cas9-Based Tool May Help Slow Antimicrobial Resistance Spread
University of Exeter
Researchers apply CRISPR-Cas9 editing to bacterial plasmids, exploit bacteria’s immune system
Bioluminescent Proteins Could Help Diagnose Viral Diseases
American Chemical Society
An innovative combination of simple molecular techniques detected SARS-CoV-2 RNA in 20 minutes and with high sensitivity